SYNTIS BIO INC

SYNTIS BIO INC is a biotech company in Boston, United States, founded in 2024. It has raised $44.9M across 5 rounds, most recently a $325K Grant in August 2025.

Home - Syntis

Employees
11–50
Founded
2024
Website
syntis.bio
Total Funding
$44.9M
Last Round
$325K GrantAug 2025
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 4 investors for this company. The full record is or through the API.

About

Syntis Bio is a clinical-stage biopharmaceutical company developing transformative therapies that harness the small intestine, either by creating a transient protective barrier or by markedly enhancing drug efficacy, enabling oral treatments for patients with serious and underserved conditions. Syntis Bio began with a moment of inspiration in the Langer and Traverso Labs at MIT after being tasked by the Bill & Melinda Gates Foundation to enhance the bioavailability of oral therapies for children in low-resource settings. SYNT, or SYNtheticTissue-lining, harnesses mussel-inspired polymer chemistry to deliver a safe, transient polymer coating to specific tissues within the GI tract and can sustain therapeutic activity in the small intestine for up to 24 hours.

Summary

It lists 11–50 employees. It has raised $44.9M in total across 5 rounds, most recently a $325K Grant round in Aug 2025. Investors include National Institutes of Health, Cerberus Ventures and Mansueto Investments.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase I (NIH)Aug 2025
$325K

Sign up to see all 5 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SYNTIS BIO INC on Indexed.vc
<a href="https://indexed.vc/companies/syntis-bio-inc"><img src="https://indexed.vc/api/badge/company/syntis-bio-inc" alt="SYNTIS BIO INC on Indexed.vc" width="260" height="76" /></a>